Literature DB >> 21450199

Characteristics of patients with sulphonurea-induced hypoglycemia.

Yael Dinur Schejter1, Elliot Turvall, Zvi Ackerman.   

Abstract

BACKGROUND/AIM: Sulphonylurea (SU) agents continue to be a cornerstone of the therapy of type 2 diabetes mellitus (T2DM). Hypoglycemia is the most dangerous side effect of SU. Identifying the characteristics of patients with SU-induced hypoglycemia (SUIH) may help in reducing its frequency.
METHODS: All consecutive admissions of patients with SUIH, between 2000 and 2008, were retrospectively reviewed.
RESULTS: Over the study period, 4702 patients with type 2 diabetes mellitus were admitted to the department of medicine. Of these, 155 patients were admitted because of SUIH. Most of these patients were elderly, had multiple comorbid situations, and were taking multiple medications. Almost a third of the patients had a history of recent changes in the use of their medications. Various infectious complications (urinary, lung, skin, and peritoneal) occurred in 43% of patients. Renal failure was a frequent finding at admission (44% of patients had creatinine plasma levels > 120 μmol/L). Poor oral intake before admission was reported by 31% of patients. Markers of malnutrition (low serum levels of albumin, iron, vitamin B-12, and folic acid) were frequently found in most patients. Mean hemoglobin A1C levels were in the low abnormal levels. A major vascular event during hospitalization co-occurred in 11% of patients. Three patients died during the hospital admission for SUIH.
CONCLUSIONS: Elderly fragile patients with multiple comorbid situations including renal failure and tight glycemic control are prone to develop SUIH. Sulphonylurea agents should be avoided in such patients. An episode of SUIH should be considered as an alarming prognostic marker. Copyright Â
© 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21450199     DOI: 10.1016/j.jamda.2010.07.014

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  7 in total

1.  Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus.

Authors:  Ayami Kajiwara; Ayana Kita; Junji Saruwatari; Kentaro Oniki; Kazunori Morita; Masato Yamamura; Motoji Murase; Haruo Koda; Seisuke Hirota; Tadao Ishizuka; Kazuko Nakagawa
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

Review 2.  Update on the treatment of type 2 diabetes mellitus.

Authors:  Juan José Marín-Peñalver; Iciar Martín-Timón; Cristina Sevillano-Collantes; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2016-09-15

Review 3.  Adverse drug events as a cause of hospitalization in older adults.

Authors:  Fabio Salvi; Annalisa Marchetti; Federica D'Angelo; Massimo Boemi; Fabrizia Lattanzio; Antonio Cherubini
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

4.  Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics.

Authors:  J M Khalid; M Raluy-Callado; B H Curtis; K S Boye; A Maguire; M Reaney
Journal:  Int J Clin Pract       Date:  2013-09-23       Impact factor: 2.503

Review 5.  Glycemic variability and cardiovascular disease in patients with type 2 diabetes.

Authors:  Marcela Martinez; Jimena Santamarina; Adrian Pavesi; Carla Musso; Guillermo E Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

Review 6.  Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Vasc Health Risk Manag       Date:  2013-04-24

7.  Temporal patterns of hypoglycaemia and burden of sulfonylurea-related hypoglycaemia in UK hospitals: a retrospective multicentre audit of hospitalised patients with diabetes.

Authors:  Rajesh Rajendran; Christopher Kerry; Gerry Rayman
Journal:  BMJ Open       Date:  2014-07-09       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.